Table.1 Sample characteristics in mean (standard deviation) or frequency (percent) according to general obesity phenotypes in 6517 women in the SAMINOR 1 Survey (2003–2004)
Metabolically healthy non-obesity (N = 3095, 47.5%) | Metabolically unhealthy non-obesity (N = 1662, 25.5%) | Metabolically healthy obesity (N = 510, 7.8%) | Metabolically unhealthy obesity (N = 1250, 19.2%) | Total (N = 6517) | p value | |
|---|---|---|---|---|---|---|
Age (years) | 49.4 (9.4) | 57.4 (10.7) | 52.1 (10.2) | 57.4 (11.0) | 53.2 (10.8) | < 0.0011 |
Ethnicity | < 0.0012 | |||||
non-Sami | 2462 (79.5%) | 1319 (79.4%) | 349 (68.4%) | 920 (73.6%) | 5050 (77.5%) | |
Sami | 633 (20.5%) | 343 (20.6%) | 161 (31.6%) | 330 (26.4%) | 1467 (22.5%) | |
Smoking | < 0.0012 | |||||
Yes, currently | 1063 (34.3%) | 588 (35.4%) | 120 (23.5%) | 277 (22.2%) | 2048 (31.4%) | |
Yes, previously | 948 (30.6%) | 481 (28.9%) | 192 (37.6%) | 441 (35.3%) | 2062 (31.6%) | |
Never | 1084 (35.0%) | 593 (35.7%) | 198 (38.8%) | 532 (42.6%) | 2407 (36.9%) | |
Died during follow-up | 154 (5.0%) | 230 (13.8%) | 25 (4.9%) | 187 (15.0%) | 596 (9.1%) | < 0.0012 |
Cause of death | < 0.0012 | |||||
Malignant tumor | 83 (53.9%) | 63 (27.4%) | 12 (48.0%) | 60 (32.1%) | 218 (36.6%) | |
CVD | 16 (10.4%) | 73 (31.7%) | 5 (20.0%) | 58 (31.0%) | 152 (25.5%) | |
Respiratory | 19 (12.3%) | 25 (10.9%) | 3 (12.0%) | 15 (8.0%) | 62 (10.4%) | |
Other | 33 (21.4%) | 67 (29.1%) | 4 (16.0%) | 51 (27.3%) | 155 (26.0%) | |
Unknown | 3 (1.9%) | 2 (0.9%) | 1 (4.0%) | 3 (1.6%) | 9 (1.5%) | |
Alcohol consumption | < 0.0012 | |||||
Weekly | 822 (26.6%) | 296 (17.8%) | 89 (17.5%) | 132 (10.6%) | 1339 (20.5%) | |
Less than weekly | 1881 (60.8%) | 958 (57.6%) | 312 (61.2%) | 741 (59.3%) | 3892 (59.7%) | |
Never/not last year | 392 (12.7%) | 408 (24.5%) | 109 (21.4%) | 377 (30.2%) | 1286 (19.7%) | |
Leisure-time physical activity | < 0.0012 | |||||
Sedentary | 594 (19.2%) | 394 (23.7%) | 140 (27.5%) | 397 (31.8%) | 1525 (23.4%) | |
Light | 2082 (67.3%) | 1100 (66.2%) | 324 (63.5%) | 751 (60.1%) | 4257 (65.3%) | |
Moderate-hard | 419 (13.5%) | 168 (10.1%) | 46 (9.0%) | 102 (8.2%) | 735 (11.3%) | |
Education (years) | 12.6 (3.9) | 10.6 (3.7) | 11.6 (4.1) | 10.5 (3.9) | 11.6 (4.0) | < 0.0011 |
General obesity | 0 (0.0%) | 0 (0.0%) | 510 (100.0%) | 1250 (100.0%) | 1760 (27.0%) | |
Metabolic syndrome | 0 (0.0%) | 948 (57.0%) | 0 (0.0%) | 990 (79.2%) | 1938 (29.7%) | < 0.0012 |
Hypertension | 802 (25.9%) | 1173 (70.6%) | 176 (34.5%) | 1023 (81.8%) | 3174 (48.7%) | < 0.0012 |
Increased waist circumference | 1274 (41.2%) | 1267 (76.2%) | 503 (98.6%) | 1244 (99.5%) | 4288 (65.8%) | < 0.0012 |
Low HDL cholesterol | 542 (17.5%) | 768 (46.2%) | 102 (20.0%) | 768 (61.4%) | 2180 (33.5%) | < 0.0012 |
Elevated triglycerides | 308 (10.0%) | 810 (48.7%) | 59 (11.6%) | 792 (63.4%) | 1969 (30.2%) | < 0.0012 |
Hyperglycemia | 30 (1.0%) | 157 (9.4%) | 2 (0.4%) | 194 (15.5%) | 383 (5.9%) | < 0.0012 |
Stroke | 0 (0.0%) | 68 (4.5%) | 0 (0.0%) | 37 (3.2%) | 105 (1.7%) | < 0.0012 |
Missing data | 3 | 166 | 2 | 83 | 254 | |
Angina pectoris | 0 (0.0%) | 146 (9.8%) | 0 (0.0%) | 134 (11.4%) | 280 (4.5%) | < 0.0012 |
Missing data | 3 | 167 | 2 | 73 | 245 | |
Myocardial infarction | 0 (0.0%) | 58 (3.9%) | 0 (0.0%) | 36 (3.1%) | 94 (1.5%) | < 0.0012 |
Missing data | 3 | 165 | 2 | 80 | 250 | |
Diabetes | 0 (0.0%) | 101 (6.7%) | 0 (0.0%) | 133 (11.3%) | 234 (3.7%) | < 0.0012 |
Missing data | 3 | 163 | 2 | 74 | 242 | |
Blood pressure-lowering drug | 0 (0.0%) | 713 (43.8%) | 0 (0.0%) | 629 (50.9%) | 1342 (20.8%) | < 0.0012 |
Missing data | 3 | 36 | 2 | 14 | 55 | |
Cholesterol-lowering drug | 0 (0.0%) | 460 (29.0%) | 0 (0.0%) | 303 (25.5%) | 763 (12.0%) | < 0.0012 |
Missing data | 3 | 75 | 2 | 60 | 140 | |
Glucose-lowering drug | 0 (0.0%) | 96 (6.3%) | 0 (0.0%) | 108 (9.3%) | 204 (3.2%) | < 0.0012 |
Missing data | 3 | 136 | 2 | 93 | 234 |